Page last updated: 2024-12-08

1,2-pentadecanoylphosphatidylcholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

## 1,2-Pentadecanoylphosphatidylcholine: A Synthetic Phospholipid for Research

1,2-Pentadecanoylphosphatidylcholine (1,2-dipentadecanoyl-sn-glycero-3-phosphocholine, or DPPC) is a **synthetic phospholipid** that closely mimics the structure of **dipalmitoylphosphatidylcholine (DPPC)**, a major component of **lung surfactant**. Lung surfactant is a complex mixture of lipids and proteins that lines the alveoli (tiny air sacs) in the lungs. It plays a crucial role in **reducing surface tension** and preventing the alveoli from collapsing during exhalation.

**Why is 1,2-Pentadecanoylphosphatidylcholine important for research?**

* **Model system for lung surfactant:** DPPC is a key component of lung surfactant and exhibits similar properties to natural lung surfactant. 1,2-Pentadecanoylphosphatidylcholine is a convenient and well-characterized synthetic analog that allows researchers to study the behavior of lung surfactant in a simplified, controlled environment.
* **Studies of lipid interactions:** DPPC, and its synthetic analog 1,2-pentadecanoylphosphatidylcholine, are often used in research to study the interactions of lipids with other molecules, such as proteins and drugs. This is important for understanding the structure and function of biological membranes.
* **Drug delivery applications:** 1,2-Pentadecanoylphosphatidylcholine can be used as a component of liposomes, which are tiny vesicles that can encapsulate and deliver drugs to specific target cells. This has potential applications in drug delivery, gene therapy, and other biomedical fields.
* **Understanding lung disease:** The properties of 1,2-pentadecanoylphosphatidylcholine and its interaction with other molecules can be studied to better understand the mechanisms behind lung diseases like respiratory distress syndrome (RDS), which is characterized by a deficiency in lung surfactant. This can lead to the development of new therapies for these conditions.

**Advantages of using 1,2-Pentadecanoylphosphatidylcholine:**

* **High purity and homogeneity:** Synthetic phospholipids like 1,2-pentadecanoylphosphatidylcholine can be produced with high purity and homogeneity, which is important for reliable and reproducible research results.
* **Controlled composition:** The composition of synthetic phospholipids is well-defined and can be easily manipulated, allowing for controlled studies of specific lipid interactions.
* **Cost-effective:** Synthetic phospholipids are generally less expensive than natural lung surfactant, making them an attractive option for research.

**Limitations of using 1,2-Pentadecanoylphosphatidylcholine:**

* **Simplification of the system:** 1,2-Pentadecanoylphosphatidylcholine represents only a small portion of the complex mixture that constitutes natural lung surfactant.
* **Limited biological relevance:** While 1,2-pentadecanoylphosphatidylcholine mimics some properties of DPPC, it doesn't capture the complete complexity of the lung surfactant system.

Overall, 1,2-Pentadecanoylphosphatidylcholine is a valuable tool for researchers studying lung surfactant, lipid interactions, and drug delivery. Its well-characterized properties and advantages make it an important model system for understanding the behavior of this crucial biological component.

Cross-References

ID SourceID
PubMed CID134308
MeSH IDM0112510

Synonyms (9)

Synonym
1,2-dipentadecanoyl-sn-glycero-3-phosphatidylcholine
pentadecanoic acid, 1-((((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)methyl)-1,2-ethanediyl ester
dpenpc
1,2-pentadecanoyl-sn-glycero-3-phosphocholine
1,2-pentadecanoylphosphatidylcholine
3-{[(2,3-dihydroxypropoxy)(hydroxy)phosphoryl]oxy}-2-(pentadecanoyloxy)propyl pentadecanoate
83588-03-8
DTXSID501003587
pg 15:0_15:0
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (30.00)18.7374
1990's2 (20.00)18.2507
2000's3 (30.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.05 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]